U.S. Markets open in 4 hrs 4 mins

Myriad Genetics, Inc. (MYGN)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
21.15+0.07 (+0.33%)
At close: 4:00PM EDT
People also watch
PDLIINCYVRTXNBIXALKS
Interactive chart
Previous Close21.08
Open21.05
Bid15.28 x 100
Ask0.00 x
Day's Range21.04 - 21.73
52 Week Range15.15 - 35.35
Volume631,386
Avg. Volume1,218,438
Market Cap1.44B
Beta0.11
PE Ratio (TTM)45.19
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube16 hours ago

    ETFs with exposure to Myriad Genetics, Inc. : May 22, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Myriad Genetics, Inc. Here are 5 ETFs with the largest exposure to MYGN-US. Comparing the performance and risk of Myriad Genetics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube14 days ago

    ETFs with exposure to Myriad Genetics, Inc. : May 9, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Myriad Genetics, Inc. Here are 5 ETFs with the largest exposure to MYGN-US. Comparing the performance and risk of Myriad Genetics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Myriad Genetics, Inc. :MYGN-US: Earnings Analysis: Q3, 2017 By the Numbers : May 8, 2017
    Capital Cube15 days ago

    Myriad Genetics, Inc. :MYGN-US: Earnings Analysis: Q3, 2017 By the Numbers : May 8, 2017

    Categories: Yahoo FinanceGet free summary analysis Myriad Genetics, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Myriad Genetics, Inc. – BioMarin Pharmaceutical Inc., Exact Sciences Corporation, Bio-Rad Laboratories, Inc. Class A and Abbott Laboratories (BMRN-US, EXAS-US, BIO-US and ABT-US) that have also reported for ... Read more (Read more...)